{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:10:11Z","timestamp":1792300211757,"version":"4.4.0"},"reference-count":40,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T00:00:00Z","timestamp":1456272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Kawasaki syndrome (KS) is the most relevant cause of heart disease in children living in developed countries. Intravenous immunoglobulin (IVIG) has a preventive function in the formation of coronary artery abnormalities and a poor strictly-curative action in established coronary damage. More than two decades ago, the Harada score was set to assess which children with KS should be subject to administration of IVIG, evaluating retrospectively a large cohort of patients with regard to age, sex and laboratory data. Nowadays, high dose IVIG is administered to all children with a confirmed diagnosis of KS, but a tool for predicting non-responsiveness to the initial infusion of IVIG has not been found. The prediction of IVIG resistance is a crucial issue, as recognising these high-risk patients should consent the administration of an intensified initial treatment in combination with IVIG in order to prevent coronary injuries. Few reports have focused on factors, referring to both clinical parameters and laboratory data at the onset of KS, in order to predict which patients might be IVIG non-responsive. We have analysed three different risk scores which were formulated to predict IVIG resistance in Japanese children with typical KS, but their application in non-Japanese patients or in those with incomplete and atypical patterns of the disease has been studied in a fragmentary way. Overall, our analysis showed that early and definite ascertainment of likely IVIG non-responders who require additional therapies reducing the development of coronary artery involvement in children with KS is still a challenge.<\/jats:p>","DOI":"10.3390\/ijms17030278","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T17:11:42Z","timestamp":1456333902000},"page":"278","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-7779","authenticated-orcid":false,"given":"Donato","family":"Rigante","sequence":"first","affiliation":[{"name":"Institute of Pediatrics, Universit\u00e0 Cattolica Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, Rome 00168, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Andreozzi","sequence":"additional","affiliation":[{"name":"Institute of Pediatrics, Universit\u00e0 Cattolica Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, Rome 00168, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Fastiggi","sequence":"additional","affiliation":[{"name":"Institute of Pediatrics, Universit\u00e0 Cattolica Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, Rome 00168, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Bracci","sequence":"additional","affiliation":[{"name":"Institute of Pediatrics, Universit\u00e0 Cattolica Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, Rome 00168, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Natale","sequence":"additional","affiliation":[{"name":"Institute of Pediatrics, Universit\u00e0 Cattolica Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, Rome 00168, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4103-2837","authenticated-orcid":false,"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[{"name":"Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milan 20122, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,2,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, American Academy of Pediatrics. Diagnosis, treatment, and long-term management in Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.autrev.2011.04.005","article-title":"Kawasaki disease: Current aspects on aetiopathogenesis and therapeutic management","volume":"10","author":"Alexoudi","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2013.04.004","article-title":"The role of infection in Kawasaki syndrome","volume":"67","author":"Principi","year":"2013","journal-title":"J. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Rigante, D., Tarantino, G., and Valentini, P. (2015). Non-infectious makers of Kawasaki syndrome: Tangible or elusive triggers?. Immunol. Res.","DOI":"10.1007\/s12026-015-8679-4"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","article-title":"High-dose intravenous \u03b3 globulin for Kawasaki disease","volume":"2","author":"Furusho","year":"1984","journal-title":"Lancet"},{"key":"ref_6","first-page":"301","article-title":"Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications","volume":"11","author":"Pardeo","year":"2007","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1542\/peds.96.6.1057","article-title":"The prevention of coronary artery aneurysm in Kawasaki disease: A meta-analysis on the efficacy of aspirin and immunoglobulin treatment","volume":"96","author":"Durongpisitkul","year":"1995","journal-title":"Pediatrics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00296-009-1337-1","article-title":"Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome","volume":"30","author":"Rigante","year":"2010","journal-title":"Rheumatol. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1442-200X.1991.tb02612.x","article-title":"Intravenous \u03b3-globulin treatment in Kawasaki disease","volume":"33","author":"Harada","year":"1991","journal-title":"Acta Paediatr. Jpn."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1542\/hpeds.2014-0008","article-title":"The Harada score in the US population of children with Kawasaki disease","volume":"4","author":"Tewelde","year":"2014","journal-title":"Hosp. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2008-0730","article-title":"Treatment of Kawasaki disease: Analysis of 27 US pediatric hospitals from 2001 to 2006","volume":"124","author":"Son","year":"2009","journal-title":"Pediatrics"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1442-200X.1983.tb01683.x","article-title":"Evaluation method for the degree of seriousness in Kawasaki disease","volume":"25","author":"Asai","year":"1983","journal-title":"Acta Paediatr. Jpn."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0002-9149(86)90348-6","article-title":"Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms","volume":"58","author":"Nakano","year":"1986","journal-title":"Am. J. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0002-9149(98)00116-7","article-title":"A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group","volume":"81","author":"Beiser","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1067\/mpd.2000.104815","article-title":"Prediction of non-responsiveness to intravenous high-dose \u03b3-globulin therapy in patients with Kawasaki disease at onset","volume":"137","author":"Fukunishi","year":"2000","journal-title":"J. Pediatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","article-title":"Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease","volume":"149","author":"Egami","year":"2006","journal-title":"J. Pediatr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","article-title":"Prediction of non-responsiveness to standard high-dose \u03b3-globulin therapy in patients with acute Kawasaki disease before starting initial treatment","volume":"166","author":"Sano","year":"2007","journal-title":"Eur. J. Pediatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpeds.2007.12.021","article-title":"Resistance to intravenous immunoglobulin in children with Kawasaki Disease","volume":"153","author":"Tremoulet","year":"2008","journal-title":"J. Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0022-3476(98)70229-X","article-title":"Coronary artery dimensions may be misclassified as normal in Kawasaki disease","volume":"133","author":"Colan","year":"1998","journal-title":"J. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jpeds.2003.12.033","article-title":"Early intravenous \u03b3-globulin treatment for Kawasaki disease: The nationwide surveys in Japan","volume":"144","author":"Muta","year":"2004","journal-title":"J. Pediatr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1542\/peds.105.6.e78","article-title":"Initial intravenous \u03b3 globulin treatment failure in Kawasaki disease","volume":"105","author":"Wallace","year":"2000","journal-title":"Pediatrics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00246-002-0216-2","article-title":"Immunoglobulin failure and retreatment in Kawasaki disease","volume":"24","author":"Durongpisitkul","year":"2003","journal-title":"Pediatr. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00006454-199812000-00009","article-title":"Intravenous \u03b3-globulin treatment and retreatment in Kawasaki disease. US\/Canadian Kawasaki Syndrome Study Group","volume":"17","author":"Burns","year":"1998","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jpeds.2010.10.031","article-title":"Pediatric Heart Network Investigators. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance","volume":"158","author":"Sleeper","year":"2011","journal-title":"J. Pediatr."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kanamitzu, K., Kakimoto, H., Shimada, A., Nakata, Y., Ochi, H., Watanabe, H., Iwasaki, Y., Tokorodani, C., Kanazawa, A., and Maruyama, H. (2015). Verification of risk scores to predict intravenous immunoglobulin resistance in incomplete Kawasaki disease. Pediatr. Int.","DOI":"10.1111\/ped.12755"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00246-010-9801-y","article-title":"Acute-phase reactants and a supplemental diagnostic aid for Kawasaki disease","volume":"31","author":"Huang","year":"2010","journal-title":"Pediatr. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5152\/balkanmedj.2015.151108","article-title":"Usefulness of neutrophil to lymphocyte ratio in prediction of coronary artery lesions in patients with Kawasaki disease","volume":"32","author":"Demir","year":"2015","journal-title":"Balkan. Med. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.amjcard.2015.04.021","article-title":"Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease","volume":"116","author":"Ha","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/1756-185X.12082","article-title":"Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients","volume":"16","author":"Sato","year":"2013","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Burgner, D., Davila, S., Breunis, W.B., Ng, S.B., Li, Y., Bonnard, C., Ling, L., Wright, V.J., Thalamuthu, A., and Odam, M. (2009). A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PLoS Genet., 5.","DOI":"10.1371\/journal.pgen.1000319"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00130832-200210000-00002","article-title":"The value of isolated populations in genetic studies of allergic disease","volume":"2","author":"Laitinen","year":"2002","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_34","first-page":"52","article-title":"ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease","volume":"13","author":"Onouchi","year":"2011","journal-title":"Pharm. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCGENETICS.110.940858","article-title":"Transforming growth factor-\u03b2 signaling pathway in patients with Kawasaki disease","volume":"4","author":"Shimizu","year":"2011","journal-title":"Circ. Cardiov. Genet."},{"key":"ref_36","first-page":"CD004000","article-title":"Intravenous immunoglobulin for the treatment of Kawasaki disease in children","volume":"4","author":"Baumer","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_37","first-page":"205","article-title":"Correlates of coronary artery aneurysm formation in patients with Kawasaki disease","volume":"141","author":"Daniels","year":"1987","journal-title":"Am. J. Dis. Child."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3476(86)80878-2","article-title":"Kawasaki disease: Review of risk factors for coronary aneurysms","volume":"108","author":"Koren","year":"1986","journal-title":"J. Pediatr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1542\/peds.80.6.828","article-title":"Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: Risk factors and role of aspirin","volume":"80","author":"Ichida","year":"1987","journal-title":"Pediatrics"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1546-0096-9-17","article-title":"Kawasaki syndrome: An intriguing disease with numerous unsolved dilemmas","volume":"9","author":"Falcini","year":"2011","journal-title":"Pediatr. Rheumatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/3\/278\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:19:36Z","timestamp":1760210376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/3\/278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,24]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3]]}},"alternative-id":["ijms17030278"],"URL":"https:\/\/doi.org\/10.3390\/ijms17030278","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,24]]}}}